These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24457290)

  • 21. Abnormalities in the stride length-cadence relation in parkinsonian gait.
    Morris M; Iansek R; Matyas T; Summers J
    Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptual errors increase with movement duration and may contribute to hypokinesia in Parkinson's disease.
    Koop MM; Hill BC; Bronte-Stewart HM
    Neuroscience; 2013 Jul; 243():1-13. PubMed ID: 23542737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Parkinson's disease on proprioceptively based on-line movement control.
    Mongeon D; Blanchet P; Bergeron S; Messier J
    Exp Brain Res; 2015 Sep; 233(9):2707-21. PubMed ID: 26055990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bradykinesia and hypokinesia in Parkinson's disease: what's in a name?
    van Hilten JJ; van Eerd AA; Wagemans EA; Middelkoop HA; Roos RA
    J Neural Transm (Vienna); 1998; 105(2-3):229-37. PubMed ID: 9660100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability, regularity and coupling measures distinguish PD tremor from voluntary 5Hz tremor.
    Morrison S; Cortes N; Newell KM; Silburn PA; Kerr G
    Neurosci Lett; 2013 Feb; 534():69-74. PubMed ID: 23206750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Movement Entropy during Community Dance Programs for People with Parkinson's Disease and Older Adults: A Cohort Study.
    Gates P; Discenzo FM; Kim JH; Lemke Z; Meggitt J; Ridgel AL
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A little trouble getting started: Initial slowness in Parkinson's disease step negotiation.
    Stone AE; Skinner JW; Lee HK; Hass CJ
    Gait Posture; 2017 Sep; 57():97-101. PubMed ID: 28582720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
    Ghassemi M; Lemieux S; Jog M; Edwards R; Duval C
    Brain Res Bull; 2006 May; 69(5):512-8. PubMed ID: 16647580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease.
    Stegemöller EL; Simuni T; MacKinnon C
    Mov Disord; 2009 Jun; 24(8):1162-9. PubMed ID: 19412952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of repetitive wrist movements in Parkinson's disease.
    Pastor MA; Jahanshahi M; Artieda J; Obeso JA
    Brain; 1992 Jun; 115 ( Pt 3)():875-91. PubMed ID: 1628206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effects of imposed extension and flexion movements on Parkinsonian rigidity.
    Xia R; Markopoulou K; Puumala SE; Rymer WZ
    Clin Neurophysiol; 2006 Oct; 117(10):2302-7. PubMed ID: 16920016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease.
    Negrotti A; Secchi C; Gentilucci M
    Neuropsychologia; 2005; 43(3):450-9. PubMed ID: 15707620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased bradykinesia in Parkinson's disease with increased movement complexity: elbow flexion-extension movements.
    Moroney R; Heida C; Geelen J
    J Comput Neurosci; 2008 Dec; 25(3):501-19. PubMed ID: 18618234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic treatment modulates sensory attenuation at the onset of the movement in Parkinson's disease: A test of a new framework for bradykinesia.
    Macerollo A; Chen JC; Korlipara P; Foltynie T; Rothwell J; Edwards MJ; Kilner JM
    Mov Disord; 2016 Jan; 31(1):143-6. PubMed ID: 26749120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic medication boosts action-effect binding in Parkinson's disease.
    Moore JW; Schneider SA; Schwingenschuh P; Moretto G; Bhatia KP; Haggard P
    Neuropsychologia; 2010 Mar; 48(4):1125-32. PubMed ID: 20018200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graphical Tasks to Measure Upper Limb Function in Patients With Parkinson's Disease: Validity and Response to Dopaminergic Medication.
    Smits EJ; Tolonen AJ; Cluitmans L; van Gils M; Zietsma RC; Borgemeester RW; van Laar T; Maurits NM
    IEEE J Biomed Health Inform; 2017 Jan; 21(1):283-289. PubMed ID: 26625435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia?
    Weinberger M; Hutchison WD; Dostrovsky JO
    Exp Neurol; 2009 Sep; 219(1):58-61. PubMed ID: 19460368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.